A Methylation Panel for Bladder Cancer
- Abbreviated Name
- A Methylation Panel for Bladder Cancer
- Lead Investigator
- Gazdar, Adi — UT Southwestern Medical Center
- Coordinating Investigator
- Gazdar, Adi — UT Southwestern Medical Center
- Involved Investigators
-
- Feng, Ziding — Fred Hutchinson Cancer Center
- Wagner, Andrew — Beth Israel Deaconess Medical Center
- Sidransky, David — Johns Hopkins University School of Medicine
- Leach, Robin J — University of Texas Health Science Center at San Antonio
- Sanda, Martin — Emory University
- Czerniak, Bogdan — The University of Texas MD Anderson Cancer Center
- Gazdar, Adi — UT Southwestern Medical Center
- Cairns, Paul — Fox Chase Cancer Center
Abstact
Aims
1) Participate in a prevalidation study for methylation based detection of bladder cancer. 2) Collect voided urine specimens from patients with a) invasive carcinomas, b) non-invasive carcinomas, and c) patients with urologic diseases who are free of cancer, including patients with hematuria 3) Test the panel of three methylation markers described in the Preliminary DAta for their ability to identify individuals with bladder cancer and to differentiate between invasive and non-invasive cancers
Analytic Method
Biomarkers
- No biomarkers available at this time for this protocol
Data Collections
- No data available at this time for this protocol
- Protocol ID
- 258
- Field of Research
- Proteomics
- Collaborative Group
- Prostate and Urologic Cancers Research Group
- Cancer Types
-
- Malignant neoplasm of bladder